Phlebaven, 500 mg 32 pcs
€1.00
Out of stock
(E-mail when Stock is available)
The drug Phlebaven® is indicated for the therapy of symptoms of chronic vein diseases (elimination and relief of symptoms).
Therapy of symptoms of venous and lymphatic insufficiency:
- pain;
- lower limb cramps;
- sensation of heaviness and expansion in legs;
- “tired legs”
therapy of manifestations of venous-lymphatic insufficiency:
- lower extremity edema;
- trophic changes of the skin and subcutaneous tissue;
- venous trophic ulcers.
Symptomatic therapy of acute and chronic hemorrhoids.
Active ingredient
Purified micronized flavonoid fraction (diosmin, flavonoids in terms of hesperidin)
Composition
for 1 tablet
Kernel:
Purified micronized flavonoid fraction, substance-granules 613.00 mg
[Active substance substance-granules:
Purified micronized flavonoid fraction [diosmin (90%) 450 mg, flavonoids converted to hesperidin (10%) 50 mg] 500.00 mg
Auxiliary substances of substance-granules:
Microcrystalline cellulose, povidone K-30]
Auxiliary substances:
Sodium carboxymethyl starch, talc, magnesium stearate
Shell film:
Opadray Orange 03H325991
1 Opadray Orange 03H32599 contains:
– hypromellose
– -titanium dioxide (E171)
– talk
– propylene glycol
– – yellow iron oxide dye (E172)
– – Red iron oxide dye (E172)
How to take, the dosage
Orally.
The recommended dose for venous-lymphatic insufficiency is 2 tablets per day (in one or two doses): in the morning, during the day and/or in the evening, with meals.
The duration of treatment may be several months (up to 12 months). In case of recurrence of symptoms, upon the doctor’s recommendation, the course of treatment may be repeated.
The recommended dose for acute hemorrhoids is 6 tablets per day: 3 tablets in the morning and 3 tablets in the evening for 4 days, then 4 tablets per day: 2 tablets in the morning and 2 tablets in the evening for the next 3 days.
The recommended dose for chronic hemorrhoids is 2 tablets per day.
Interaction
Not noted.
Make sure you tell your doctor about all the medications you are taking.
Special Instructions
- Before starting to take the drug Phlebaven®, it is recommended to consult with your doctor.
- In acute hemorrhoids, the use of Flebaven® does not replace specific treatment of other anal disorders. The duration of treatment should not exceed the time specified in the section “Dosage and administration”. If symptoms do not disappear after the recommended course of therapy, you should be examined by a proctologist, who will select further therapy.
- With venous circulatory disorders, the maximum effect of therapy is achieved by a combination of therapy with a healthy (balanced) lifestyle: it is advisable to avoid long hours in the sun, staying on your feet for long hours, and reduction of excessive body weight. Walking and in some cases, wearing special stockings helps to improve blood circulation.
Please see your doctor immediately if your condition worsens or does not improve with treatment.
No effect.
Synopsis
Capsule-shaped, biconvex, film-coated tablets with light orange-pink color.
Breakage appearance of the tablets: rough yellow to brownish-yellow mass with light orange-pink film coating.
Contraindications
- High sensitivity to the active substances or excipients in the drug.
- It is not recommended to take the drug during breast-feeding.
.
Side effects
Side effects of the combination hesperidin + diosmin observed in clinical trials were mild. Gastrointestinal disorders (diarrhea, dyspepsia, nausea, vomiting) were mostly observed.
World Health Organization (WHO) recommended side effect frequency classification:
very frequently ≥1/10
often ≥ 1/100 to < 1/10
infrequently from ≥ 1/1000 to < 1/100
rarely from ≥ 1/10000 to < 1/1000
very rarely < 1/10000
frequency is unknown cannot be estimated from available data.
From the central nervous system:
rarely: dizziness, headache, general malaise.
From the digestive system:
often:diarrhea, dyspepsia, nausea, vomiting;
frequency unknown: abdominal pain.
Skin side:
rare: skin rash, skin itching, urticaria;
frequency unknown: isolated swelling of the face, lips, eyelids. In exceptional cases angioedema.
Overdose
No cases of overdose have been described.
In case of overdose of Flebaven®, seek medical attention immediately.
Pregnancy use
Pregnancy
Animal experiments have not shown teratogenic effects.
Till now there were no reports of adverse effects when using the drug in pregnant women.
Breast-feeding
Due to the lack of data regarding excretion of the drug with the breast milk, women during breast-feeding should not take the drug.
Effects on reproduction
Reproductive toxicity studies have shown no effects on reproduction in rats of either sex.
Similarities
Venarus, Detralex, Venolife Duo, Detravenol, Diosmin+Hesperidin, Troxactiv
Weight | 0.100 kg |
---|---|
Shelf life | 2 years. Do not use the product after the expiration date. |
Conditions of storage | At temperature not exceeding 25°C, in original packaging. Store out of reach of children. |
Manufacturer | KRKA-RUS, Russia |
Medication form | pills |
Brand | KRKA-RUS |
Other forms…
Related products
Buy Phlebaven, 500 mg 32 pcs with delivery to USA, UK, Europe and over 120 other countries.